Published in Cancer Weekly, June 5th, 2006
Study 1: Malignant melanoma could be treated by hyperthermic isolated limb perfusion (HILP).
According to a recent report, researchers in Germany conducted a study "to analyse results with a standardized HILP procedure in terms of response rate, recurrence pattern and complication rate. From 1992 to 2003 HILP with melphalan and dactinomycin was performed in 101 patients with loco-regional metastases of malignant melanoma of the limbs."
"Among these were 66 women and 35 men with a median age of 62 years," explained C. Knorr and colleagues,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.